Emphysematous Cholecystitis — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Clostridium perfringens and E. coli — gas-forming organisms in the context of gallbladder ischaemia (diabetes predisposes to microvascular disease)
Emphysematous cholecystitis is a severe variant of acute cholecystitis with gas in the gallbladder wall, caused by gas-forming organisms (Clostridium perfringens ~45%, E. coli, Klebsiella, anaerobes). It is strongly associated with diabetes (50% of cases) due to microvascular ischaemia of the gallbladder wall promoting anaerobic bacterial proliferation. Management is urgent cholecystectomy plus broad-spectrum IV antibiotics (Piperacillin/Tazobactam or Meropenem plus Metronidazole). Mortality is 15–25% — significantly higher than simple cholecystitis.
Reference: NICE NG104 2014 – Gallstone disease; WSES 2020 – Acute cholecystitis